Trexquant Investment LP

Position in AGIO — Agios Pharmaceuticals, Inc.

CIK 1633445 STAMFORD, CT

Position in AGIO

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$2,547,331

-$3,620,721 QoQ

Shares Held

75,298

-66.8% QoQ

Ownership

0.127%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 91% Shared 0% None 9%

Healthcare · as of Mar 31, 2026

Trexquant Investment LP holds $496,284,956 across 119 Biotechnology names. AGIO ranks #62 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRNA	Moderna, Inc.	483,971	$24,585,726
2	ALNY	Alnylam Pharmaceuticals, Inc.	61,760	$20,434,531
3	ARWR	Arrowhead Pharmaceuticals, Inc.	277,114	$17,375,047
4	EXEL	Exelixis, Inc.	390,818	$16,762,184
5	HRMY	Harmony Biosciences Holdings, Inc.	594,850	$16,661,748
6	IONS	Ionis Pharmaceuticals Inc	213,645	$16,042,603
7	CNTA	Centessa Pharmaceuticals plc	390,951	$15,528,573
8	ASND	Ascendis Pharma A/S	65,517	$14,985,703

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,547,331	75,298	-66.8%	Shares	Sole	2026-05-15
2025-12-31	$6,168,052	226,600	+130.3%	Shares	Sole	2026-02-17
2025-06-30	$3,272,817	98,401	+40.6%	Shares	Sole	2025-08-12
2024-12-31	$2,299,247	69,971	+180.3%	Shares	Sole	2025-02-12
2024-09-30	$1,109,239	24,966	-83.9%	Shares	Sole	2024-11-12
2024-06-30	$6,686,877	155,076	+155.5%	Shares	Sole	2024-08-13
2024-03-31	$1,774,546	60,689	+11.3%	Shares	Sole	2024-05-14
2023-12-31	$1,214,628	54,541	+121.6%	Shares	Sole	2024-02-09
2023-03-31	$565,360	24,613	+257.0%	Shares	Sole	2023-05-15
2021-03-31	$356,006	6,894	-40.7%	Shares	Sole	2021-05-13
2020-09-30	$406,770	11,622	+19.4%	Shares	Sole	2020-11-06
2020-06-30	$520,734	9,737	-48.6%	Shares	Sole	2020-08-07
2020-03-31	$672,700	18,960	—	Shares	Sole	2020-05-08
No filing history on record for this holder in this stock.